| Lifespan Psychiatric & Internal Medicine Services | |
|
1618 Mahan Center Blvd Ste 103 Tallahassee FL 32308-5476 | |
| (850) 999-2996 | |
| (850) 536-6439 |
| Full Name | Lifespan Psychiatric & Internal Medicine Services |
|---|---|
| Speciality | Nurse Practitioner |
| Location | 1618 Mahan Center Blvd Ste 103, Tallahassee, Florida |
| Authorized Official Name and Position | Julianne Fountain (OWNER) |
| Authorized Official Contact | 8505669190 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lifespan Psychiatric & Internal Medicine Services 1618 Mahan Center Blvd Ste 103 Tallahassee FL 32308-5476 Ph: (850) 999-2996 | Lifespan Psychiatric & Internal Medicine Services 1618 Mahan Center Blvd Ste 103 Tallahassee FL 32308-5476 Ph: (850) 999-2996 |
| NPI Number | 1659940377 |
|---|---|
| Provider Enumeration Date | 06/18/2021 |
| Last Update Date | 05/02/2024 |
| Certification Date | 05/02/2024 |
| Medicare PECOS PAC ID | 3971900929 |
|---|---|
| Medicare Enrollment ID | O20210920000186 |
News Archive
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.
A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder.
Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood have been found effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease, report University of South Florida researchers and colleagues from Saneron CCEL Therapeutics, Inc., and the Ribeirao Preto School of Medicine at the University of Sao Paulo, Brazil.
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659940377 | NPI | - | NPPES |
| Provider Name | Ryan W Novince |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164865259 PECOS PAC ID: 6204062029 Enrollment ID: I20200219002203 |
News Archive
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.
A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder.
Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood have been found effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease, report University of South Florida researchers and colleagues from Saneron CCEL Therapeutics, Inc., and the Ribeirao Preto School of Medicine at the University of Sao Paulo, Brazil.
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
› Verified 4 days ago
| Provider Name | Julianne K Fountain |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629691225 PECOS PAC ID: 4082025440 Enrollment ID: I20201117000228 |
News Archive
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.
A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder.
Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood have been found effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease, report University of South Florida researchers and colleagues from Saneron CCEL Therapeutics, Inc., and the Ribeirao Preto School of Medicine at the University of Sao Paulo, Brazil.
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
› Verified 4 days ago
| Provider Name | Heather L Chasteen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487225280 PECOS PAC ID: 8022411636 Enrollment ID: I20210720002575 |
News Archive
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.
A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder.
Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood have been found effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease, report University of South Florida researchers and colleagues from Saneron CCEL Therapeutics, Inc., and the Ribeirao Preto School of Medicine at the University of Sao Paulo, Brazil.
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
› Verified 4 days ago
News Archive
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.
A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder.
Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood have been found effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease, report University of South Florida researchers and colleagues from Saneron CCEL Therapeutics, Inc., and the Ribeirao Preto School of Medicine at the University of Sao Paulo, Brazil.
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
› Verified 4 days ago
Seasons Of Life Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 113 S Monroe St, Tallahassee, FL 32301 Phone: 850-201-7177 Fax: 850-201-7101 | |
Tallahassee Neurology Associates, P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2868 Mahan Dr, Suite 5, Tallahassee, FL 32308 Phone: 850-942-7177 Fax: 850-656-9443 | |
Psychiatry Associates Of Tallahassee, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1407 M D Ln Ste A, Tallahassee, FL 32308 Phone: 850-877-0635 Fax: 850-205-0195 | |
Dna Comprehensive Therapy Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1965 Capital Cir Ne Ste 102, Tallahassee, FL 32308 Phone: 850-671-4600 | |
Renewing Minds Counseling And Consulting Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4047 Ailanthus Ct, Tallahassee, FL 32305 Phone: 850-692-9268 | |
Dr. Peter Debelius-enemark, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1407 M D Ln Ste A, Tallahassee, FL 32308 Phone: 850-877-0635 Fax: 850-205-0195 | |
Tallahassee Therapy Associates, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 W 4th Ave, Tallahassee, FL 32303 Phone: 850-241-5707 |